Kewalramani Reshma (CIK 1735944) reported 29 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-03). Recent activity: Sell VRTX (120 shares), Sell VRTX (949 shares), Sell VRTX (240 shares), Sell VRTX (2,510 shares), Sell VRTX (3,278 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-03 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | CEO & President | Sell | 120 | $57,780 |
| 2026-03-03 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | CEO & President | Sell | 949 | $466,244 |
| 2026-03-03 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | CEO & President | Sell | 240 | $115,882 |
| 2026-03-03 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | CEO & President | Sell | 2,510 | $1.2M |
| 2026-03-03 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | CEO & President | Sell | 3,278 | $1.6M |
| 2026-03-03 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | CEO & President | Sell | 460 | $225,087 |
| 2026-03-03 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | CEO & President | Sell | 2,725 | $1.3M |
| 2026-03-03 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | CEO & President | Sell | 400 | $191,900 |
| 2026-03-03 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | CEO & President | Sell | 2,520 | $1.2M |
| 2026-03-03 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | CEO & President | Sell | 3,498 | $1.7M |
| 2026-03-03 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | CEO & President | Sell | 15,580 | $7.7M |
| 2026-03-03 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | CEO & President | Sell | 5,995 | $3.0M |
| 2026-03-03 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | CEO & President | Sell | 1,725 | $857,239 |
| 2026-02-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | CEO & President | Sell | 4,981 | $2.4M |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | CEO & President | Buy | 16,326 | $0 |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | CEO & President | Sell | 6,554 | $3.2M |
| 2026-02-18 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | CEO & President | Sell | 13,041 | $6.4M |
| 2026-02-12 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | CEO & President | Sell | 8,297 | $3.9M |
| 2026-01-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | CEO & President | Buy | 26,972 | $0 |
| 2026-01-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | CEO & President | Buy | 11,885 | $0 |
| 2025-08-07 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | CEO & President | Buy | 4,290 | $1.7M |
| 2025-08-07 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | CEO & President | Buy | 5,710 | $2.2M |
| 2025-02-28 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | CEO & President | Sell | 14,079 | $6.8M |
| 2025-02-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | CEO & President | Sell | 9,386 | $4.5M |
| 2025-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | CEO & President | Sell | 6,553 | $3.0M |
Source: SEC Form 4 filings · as of 2026-03-03